Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A165b alternative splicing via regulating SRSF1 and SRPK1

Fig. 2

The expression of TNM combined with USP39 in patients with low stage can significantly predict the survival and prognosis of patients. A Forest plot showed that the level of USP39 expression is an independent risk factor for overall survival in renal cancer patients. B ROC curve analysis for predictive the ability of single indicator TNM, single indicator TNM and combined TNM and USP39. Blue line: USP39; Green line: TNM stage; Red line: TNM stage + USP39. C For patients with low TNM stage, ROC curve analysis for the predictive ability of the expression level of USP39, TNM stage, and combined indicators. Blue line: USP39; Green line: TNM stage I − II; Red line: TNM stage I − II + USP39

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us